GtreeBNT Co Ltd (115450):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:GtreeBNT Co Ltd (115450) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9385
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
GtreeBNT Co Ltd (GtreeBNT), formerly Digital Aria, is a pharmaceutical company. The company researches and develops pharmaceutical products. It develops GBT-201 for the treatment of ophthalmologic diseases such as dry eye syndrome and neurotrophic keratopathy; and GBT-101 for treating epidermolysis bullosa dermal disease. GtreeBNT offers OKN-007 for the treatment of glioblastoma brain cancer. It also produces pumps, motors, fan motors, and transformers. The company plans to conduct clinical trials in South Korea and the US. It operates offices in Seongnam and Chilgok, South Korea. GtreeBNT is headquartered in Seongnam, South Korea.

GtreeBNT Co Ltd (115450) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
GtreeBNT Acquires Rights to OKN-007 from Oklahoma Medical Research Foundation 10
Venture Financing 11
G-treeBNT Raises USD1.4 Million in Venture Financing 11
Partnerships 12
GtreeBNT Forms Joint Venture with YuYang 12
RegeneRx Biopharma Forms Joint Venture with G-treeBNT 13
Licensing Agreements 14
GtreeBNT Enters into Licensing Agreement with RegeneRx Biopharma for RGN-137 14
RegeneRx Biopharma Enters Into Licensing Agreement With G-treeBNT (Digital Aria) For RGN-259 And RGN-137 15
Equity Offering 16
G-treeBNT Raises USD6 Million in Private Placement of Shares 16
RegeneRx Biopharma Completes Final Tranche of Private Placement of Shares for USD2.4 Million 17
GtreeBNT Co Ltd – Key Competitors 19
GtreeBNT Co Ltd – Key Employees 20
GtreeBNT Co Ltd – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Joint Venture 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GtreeBNT Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
GtreeBNT Acquires Rights to OKN-007 from Oklahoma Medical Research Foundation 10
G-treeBNT Raises USD1.4 Million in Venture Financing 11
GtreeBNT Forms Joint Venture with YuYang 12
RegeneRx Biopharma Forms Joint Venture with G-treeBNT 13
GtreeBNT Enters into Licensing Agreement with RegeneRx Biopharma for RGN-137 14
RegeneRx Biopharma Enters Into Licensing Agreement With G-treeBNT (Digital Aria) For RGN-259 And RGN-137 15
G-treeBNT Raises USD6 Million in Private Placement of Shares 16
RegeneRx Biopharma Completes Final Tranche of Private Placement of Shares for USD2.4 Million 17
GtreeBNT Co Ltd, Key Competitors 19
GtreeBNT Co Ltd, Key Employees 20
GtreeBNT Co Ltd, Other Locations 21
GtreeBNT Co Ltd, Subsidiaries 21
GtreeBNT Co Ltd, Joint Venture 21

List of Figures
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
GtreeBNT Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[GtreeBNT Co Ltd (115450):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sao Paulo Alpargatas S.A.:戦略・SWOT・企業財務分析
    Sao Paulo Alpargatas S.A. - Strategy, SWOT and Corporate Finance Report Summary Sao Paulo Alpargatas S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Brasfield & Gorrie LLC:企業の戦略・SWOT・財務分析
    Brasfield & Gorrie LLC - Strategy, SWOT and Corporate Finance Report Summary Brasfield & Gorrie LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Belden Inc (BDC):企業の財務・戦略的SWOT分析
    Belden Inc (BDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Lakeview Hotel Investment Corp.:企業の戦略・SWOT・財務情報
    Lakeview Hotel Investment Corp. - Strategy, SWOT and Corporate Finance Report Summary Lakeview Hotel Investment Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • DiaGenic ASA (NEL)-医療機器分野:企業M&A・提携分析
    Summary DiaGenic ASA (DiaGenic) is a medical device company that develops innovative in vitro diagnostic products for early detection of diseases. The company specializes in developing blood-based biomarkers. Its ADtect product is a blood test that helps distinguish mild to moderate range AD from th …
  • National Bank of Egypt S.A.E:企業の戦略・SWOT・財務情報
    National Bank of Egypt S.A.E - Strategy, SWOT and Corporate Finance Report Summary National Bank of Egypt S.A.E - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Uniper SE (UN01):企業の財務・戦略的SWOT分析
    Uniper SE (UN01) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Cherkizovo Group OJSC (GCHE):企業の財務・戦略的SWOT分析
    Cherkizovo Group OJSC (GCHE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Laboratory Corporation of America Holdings:企業の戦略・SWOT・財務分析
    Laboratory Corporation of America Holdings - Strategy, SWOT and Corporate Finance Report Summary Laboratory Corporation of America Holdings - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Edinburgh Molecular Imaging Ltd:製品パイプライン分析
    Summary Edinburgh Molecular Imaging Ltd (EM Imaging) is a clinical phase biotechnology company that develops optical molecular imaging technology. It is involved in the discovery and development of small molecules and peptides. The company designs agents to improve the diagnosis and treatment of can …
  • Probiodrug AG (PBD):企業の財務・戦略的SWOT分析
    Summary Probiodrug AG (Probiodrug) is a clinical stage biopharmaceutical company that conducts research and development of new medicines for the treatment of Alzheimer’s disease. The company provides three pipeline drug candidates such as PQ912, PBD-C06 and PQ1565. Its PQ912 drug candidate is a smal …
  • Alector LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Alector LLC (Alector) is a biotechnology company that develops therapies for immune system to cure neurodegeneration and cancer. The company discovers and develops immune modulatory therapies for Alzheimer’s disease and other neurodegenerative disorders. It combines state-of-the-art antibody …
  • Rum Group for Transportation & Tourism Investment:戦略・SWOT・企業財務分析
    Rum Group for Transportation & Tourism Investment - Strategy, SWOT and Corporate Finance Report Summary Rum Group for Transportation & Tourism Investment - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structur …
  • PT Tiphone Mobile Indonesia Tbk (TELE):企業の財務・戦略的SWOT分析
    PT Tiphone Mobile Indonesia Tbk (TELE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • PotlatchDeltic Corporation (PCH):企業の財務・戦略的SWOT分析
    PotlatchDeltic Corporation (PCH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • D.H. Cyprotels Plc:企業の戦略・SWOT・財務情報
    D.H. Cyprotels Plc - Strategy, SWOT and Corporate Finance Report Summary D.H. Cyprotels Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Lotus Pharmaceutical Co Ltd (1795):企業の財務・戦略的SWOT分析
    Summary Lotus Pharmaceutical Co Ltd (Lotus Pharmaceutical), a subsidiary of Alvogen Inc is a pharmaceutical company that develops and sells pharmaceutical products. The company provides products that are used in the treatment of rheumatology, cancer, cardiology, dyslipidemia, hypertension, woman hea …
  • Yamaha Motor Co Ltd (7272):企業の財務・戦略的SWOT分析
    Yamaha Motor Co Ltd (7272) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Alps Alpine Co Ltd (6770):企業の財務・戦略的SWOT分析
    Alps Alpine Co Ltd (6770) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Barnes & Noble, Inc.:企業の戦略・SWOT・財務情報
    Barnes & Noble, Inc. - Strategy, SWOT and Corporate Finance Report Summary Barnes & Noble, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆